1,2-cyclohexanediamine has been researched along with Melanoma in 1 studies
1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Excerpt | Relevance | Reference |
---|---|---|
"Multicellular spheroids of MDA886LN squamous carcinoma cells treated with CDDP showed intense staining on the growing periphery compared with weak but homogeneous staining within the spheroid." | 1.28 | Detection of cellular platinum using the monoclonal antibody 1C1. ( Khokhar, AR; Murray, L; Newman, RA; Nishikawa, K; Rosenblum, MG, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nishikawa, K | 1 |
Newman, RA | 1 |
Murray, L | 1 |
Khokhar, AR | 1 |
Rosenblum, MG | 1 |
1 other study available for 1,2-cyclohexanediamine and Melanoma
Article | Year |
---|---|
Detection of cellular platinum using the monoclonal antibody 1C1.
Topics: Antibodies, Monoclonal; Antibody Specificity; Binding, Competitive; Carcinoma, Squamous Cell; Cispla | 1990 |